Literature DB >> 16256875

Association of myocardial ischemia with mortality and implantable cardioverter-defibrillator therapy in patients with coronary artery disease at risk of arrhythmic death.

Abdou Elhendy1, Scott Chapman, Thomas R Porter, John Windle.   

Abstract

OBJECTIVES: We sought to assess the relation between myocardial ischemia during stress echocardiography and major events in patients with implantable cardioverter-defibrillator (ICD).
BACKGROUND: The association of myocardial ischemia with subsequent ICD therapy and mortality is unknown.
METHODS: We studied 90 patients (age 65 +/- 13 years, 27 women) with history of coronary heart disease who received ICD for primary (53 patients) or secondary (37 patients) prevention of sudden cardiac death. Sixty-five (72%) patients had a previous coronary artery bypass surgery. Patients underwent exercise treadmill or dobutamine stress echocardiography. Ischemia was defined as new or worsening wall motion abnormalities. End points were death and appropriate ICD therapy.
RESULTS: Mean ejection fraction was 34 +/- 12%. During a mean follow-up of 2.8 +/- 1.5 years, 5 patients died and 19 patients had ICD therapy. Ischemia was detected in 20 of 24 patients with subsequent events and in 24 of 66 patients without (83% vs. 36%, p < 0.001). Events occurred in 17 of the 32 patients (53%) with both ischemia and inducible ventricular tachycardia (VT) on electrophysiologic (EP) studies. None of the 16 patients without ischemia or inducible VT on EP studies had events. In a Cox multivariate analysis model, independent predictors of events were a history of spontaneous sustained VT (hazard ratio [HR] 1.9, 95% confidence interval [CI] 1.3 to 3.8), inducible VT on EP studies (HR 1.7, 95% CI 1.2 to 4.5), and ischemia (HR 2.1, 95% CI 1.2 to 3.5).
CONCLUSIONS: Ischemia during stress echocardiography is an independent predictor of death and ICD therapy in patients with coronary heart disease at high risk of arrhythmic death. Patients without inducible ischemia or VT on a previous EP study have a very low risk of events. A combination of ischemia and a positive EP study is associated with a very high risk of events.

Entities:  

Mesh:

Year:  2005        PMID: 16256875     DOI: 10.1016/j.jacc.2005.04.065

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Selection of patients for ICD therapy still under debate: Contra ICD.

Authors:  A R Ramdat Misier; M J de Boer; W P Beukema
Journal:  Neth Heart J       Date:  2006-12       Impact factor: 2.380

Review 2.  [Coronary artery disease--relevance of total coronary revascularization on the incidence of malignant arrhythmias].

Authors:  A Brandt; D C Gulba
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-12

3.  Does syncope require rhythmic and non-rhythmic evaluation in patients with previous MI?

Authors:  B Brembilla-Perrot; C Suty-Selton; F Alla; P Y Zinzius; H Blangy; B Azman; A Terrier de la Chaise; P Louis; L Groben; K Djaballah; O Selton; S Magalhaes; L Muresan; J Cedano; A Abdelaal; N Sadoul
Journal:  Heart Asia       Date:  2010-07-29

4.  Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators.

Authors:  Chi-Wen Kao; Erika Friedmann; Sue A Thomas
Journal:  Qual Life Res       Date:  2010-02-03       Impact factor: 4.147

Review 5.  Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonance.

Authors:  Victoria Delgado; Chiara Bucciarelli-Ducci; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2016-07-29       Impact factor: 5.952

Review 6.  Sudden Cardiac Death: A Review Focused on Cardiovascular Imaging.

Authors:  Valentina Barletta; Iacopo Fabiani; Conte Lorenzo; Irene Nicastro; Vitantonio Di Bello
Journal:  J Cardiovasc Echogr       Date:  2014 Apr-Jun

Review 7.  Risk Stratification of Sudden Cardiac Death After Acute Myocardial Infarction.

Authors:  An H Bui; Jonathan W Waks
Journal:  J Innov Card Rhythm Manag       Date:  2018-02-15

8.  Continuous ST-Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease.

Authors:  Tetsuya Watanabe; Keiji Hirooka; Yoshio Furukawa; Masanori Yabuki; Akio Hirata; Kazunori Kashiwase; Ryu Shutta; Takanao Mine; Hiroya Mizuno; Toshikazu Tanaka; Takahiro Doi; Akihiro Yoshida; Yuji Okuyama; Shinsuke Nanto
Journal:  J Am Heart Assoc       Date:  2018-06-30       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.